Patent · US Active

Anti-neuropilin antigen-binding proteins and methods of use thereof

US10227413B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Assignee

Potenza Therapeutics, Inc. · US

Inventors

Daniel Hicklin · Montclair, US
Cynthia Seidel-Dugan · Belmont, US
William Winston · Marlborough, US
Jose Andres SALMERON-GARCIA · Westminster, US
Nels P. Nielson · Cambridge, US
Heather Brodkin · Newton, US

Key dates

Filing date	Feb 20, 2018
Grant date	Mar 12, 2019
Priority date	—
Expiry date	Feb 20, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antigen-binding proteins (ABPs) that selectively bind to NRP-1 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.